PRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma

Yao Liu, Jia Han, Akihiro Shioya, Takeru Oyama, Xin Guo, Qian Yang, Hidetaka Uramoto, Sohsuke Yamada · 2026

Read PRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma by Yao Liu, Jia Han, Akihiro Shioya, Takeru Oyama, Xin Guo, Qian Yang, Hidetaka Uramoto, Sohsuke Yamada (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13312543.txt.

Description

Yao Liu and co-authors examine, in a 2026 study, the antioxidant enzyme PRDX4 in pancreatic ductal adenocarcinoma, one of the deadliest common cancers. Tumors of this type grow in a harsh, oxygen-poor environment thick with oxidative stress, and the authors asked whether this redox-defense protein helps them thrive and resist treatment.

Patient data linked high PRDX4 levels to aggressive disease features and shorter disease-specific survival. In cell experiments, extra PRDX4 sped growth and migration, strengthened the cells' ability to adapt to oxidative load, and kept reactive oxygen species down, alongside altered signaling through MAPK and PI3K/AKT routes. In animals, tumors with more PRDX4 grew faster, built more blood vessels, and answered gemcitabine chemotherapy more weakly. The authors propose PRDX4 as both a prognostic marker and a redox-linked drug target.

Catalog record

CREATORYao Liu, Jia Han, Akihiro Shioya, Takeru Oyama, Xin Guo, Qian Yang, Hidetaka Uramoto, Sohsuke Yamada
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82827
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13312543

Browse the full library · About the Tower of Babel